SmithKline Beecham Corporation / D. Epilepsy Consultant John Messenheimer PLLC / GlaxoSmithKline / Lamotrigine GlaxoSmithKline LLC / M.D. / /
Country
United States / /
Event
FDA Phase / /
Facility
University Comprehensive Epilepsy Center Historical Control / Neurological Surgery University of Washington Clarifying Questions BREAK INDUSTRY PRESENTATION Overview / University Medical Center Clarifying Questions FDA PRESENTATION Lamictal / /
University of Washington / New York University / office of New Drugs / Food and Drug Administration / Neurological Surgery University / Neurosciences Medicine Development Center / Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Peripheral / Mathematical Statistician Division of Biostatistics / FDA / Biostatistics Office / Information Office / American Epilepsy Society / Center for Drug Evaluation and Research / Central Nervous System Drugs Advisory Committee / /
Person
Eli Mizrahi / Robert R. Clancy / Jacqueline A. French / David M. Treiman / Russell G. Katz / Mathematical Statistician / Marshall S. Balish / Stuart Pocock / Hongyu Zhao / Xiang Ling / Thomas R. Fleming / Dean D. Kindler / Pooja Khatri / Trial Xiang Ling / Ellen J. Marder / Nancy R. Temkin / Phillip L. Pearl / Jeffrey A. Cohen / Roy Twyman / Steven Dinsmore / William H. Theodore / Thomas Thompson / Samuel A. Frank / Lily Jung Henson / John Messenheimer / Remarks Russell Katz / Britt Anderson / Norman Hershkowitz / Andrew C. Leon / Jason W. Todd / Kevin E. Chapman / Nathan B. Fountain / John M. Pellock / Diem-Kieu H. Ngo / Opening Remarks Britt Anderson / Eugene M. Laska / /
Position
speaker / Professor / Department of Neurology Director / Federal Official / Federal Officer / Professor / Director / Director / Division of Neurology Products / Acting Chair / Chair / Representative / BCPS Designated Federal Officer / Physician Project Leader / /